Stay updated on Nivolumab and Ipilimumab in Melanoma Clinical Trial
Sign up to get notified when there's something new on the Nivolumab and Ipilimumab in Melanoma Clinical Trial page.

Latest updates to the Nivolumab and Ipilimumab in Melanoma Clinical Trial page
- Check2 days agoChange DetectedThe Italy site entry was updated from Padua, Italy 35128 to Padova, Italy 35128.SummaryDifference0.0%

- Check9 days agoChange DetectedThe Melanoma topic, related topics, and MedlinePlus Genetics were removed from the page.SummaryDifference0.1%

- Check16 days agoChange DetectedNaples, Italy, 80131 was added as a location and Napoli, Italy, 80131 was removed; Melanoma and related topics, including MedlinePlus Genetics, were added to the related topics section.SummaryDifference0.1%

- Check23 days agoChange DetectedRevision label updated to v3.5.0; the previous v3.4.3 label was removed.SummaryDifference0.0%

- Check31 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3.SummaryDifference0.0%

- Check52 days agoChange DetectedRemoved the term 'Melanoma' and the 'MedlinePlus Genetics' related topics section from the study details page. This changes the visible scope of the page and its linked resources.SummaryDifference0.1%

Stay in the know with updates to Nivolumab and Ipilimumab in Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab and Ipilimumab in Melanoma Clinical Trial page.